 |
|
|
|
September 1999 Cover
|
|
Twin Cities researchers are having trouble enlisting people for VaxGen's HIV vaccine trials. So far there are 130 volunteers but the goal is 300. According to
the researchers, volunteers appear reluctant to sign on, in part, because AIDS seems more manageable to many and because of reservations about the vaccine. VaxGen
is having trouble recruiting nationally as well, having only attained 65 percent of its 5,000-volunteer target.
Editor's Note: from the Minneapolis Star-Tribune
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
